MyArkLaMiss (press release) (blog)Cancer-fighting immunotherapy recommended for FDA approvalMyArkLaMiss (press release) (blog)A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is… Continue reading
|
An Exciting New Cancer Treatment Has Just Been Endorsed by FDA
ScienceAlert During the public comment portion of the hearing, Amy Kappen, whose 5-year-old daughter underwent CAR T-cell therapy in Philadelphia, called for approval. The treatment beat back her daughter’s cancer and brought back “the sparkle” in her eyes. |
Weekly Register |
Synthetic Biology Market Headed for Growth and Global Expansion by 2024
Digital Journal Synthetic biology is the advanced technology that is developed from biology, engineering, chemistry, and computer science but the approach was ultimately changed towards therapeutics. The various application of synthetic biology includes industrial … iBio, Inc. (IBIO) Announces US Patent Granted to AzarGen …StreetInsider.com Collaboration Partner Pulls Ibio Inc (NYSEMKT:IBIO) Higher – Stock …StockNewsUnion |
CNET |
Gene therapy to kill cancer moves a step closer to market – CNET
CNET An advisory panel says it’s time patients had access to gene-altering treatments. If approved, the first to make it to market would take on a stubborn form of … |
CNET |
Gene therapy to kill cancer moves a step closer to market
CNET A new era of treating disease has moved a step closer to reality in the United States. A Food and Drug Administration panel gave a thumbs-up Wednesday to a gene therapy that involves genetically engineering a patient’s T-cells to fight a particular … |
CNET |
Gene therapy to kill cancer moves a step closer to market
CNET A new era of treating disease has moved a step closer to reality in the United States. A Food and Drug Administration panel gave a thumbs-up Wednesday to a gene therapy that involves genetically engineering a patient’s T-cells to fight a particular … |
NPR |
‘Living Drug’ That Fights Cancer By Harnessing Immune System Clears Key Hurdle
NPR The new treatment is known as CAR-T cell immunotherapy. It works by removing key immune system cells known as T cells from the patient so scientists can genetically modify them to seek out and attack only cancer cells. That’s why some scientists refer … Cancer-fighting immunotherapy recommended for FDA approvalLocal 10 Novel cancer treatment wins endorsement of FDA advisersWashington Post Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com Chicago Tribune –Drug Discovery & Development –Reuters –FDA all 133 news articles » |